form_type
stringclasses 2
values | accession_number
stringlengths 20
20
| filing_date
stringlengths 14
14
| quarter_ending
stringclasses 172
values | company_name
stringlengths 5
54
| text
stringlengths 101
2.42k
| entities
listlengths 1
18
|
|---|---|---|---|---|---|---|
10-Q | 0001125345-19-000112 | 20191106160806 | 20190930 | MACROGENICS INC | The Company also has an agreement with Incyte, which was entered into in 2018, under which the Company is to perform development and manufacturing services for Incyte’s clinical needs of MGA012 (Incyte Clinical Supply Agreement). The Company evaluated the agreement under ASC 606 and identified one performance obligation under the agreement: to perform services related to manufacturing the clinical supply of MGA012. The transaction price is based on the costs incurred to develop and manufacture drug product and drug substance, and is recognized over time as the services are provided, as the performance by the Company does not create an asset with an alternative use and the Company has an enforceable right to payment for the performance completed to date. During the three months ended September 30, 2019 and 2018, the Company recognized revenue of $4.9 million and $6.1 million, respectively, for services performed under the Incyte Clinical Supply Agreement. The Company recognized revenue of $13.1 million and $16.0 million for services performed under the Incyte Clinical Supply Agreement during the nine months ended September 30, 2019 and 2018, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 865,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 862,
"start_date_for_period": "2019-07-01",
"value": 4900000
},
{
"currency_/_unit": "USD",
"end_character": 882,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 879,
"start_date_for_period": "2018-07-01",
"value": 6100000
},
{
"currency_/_unit": "USD",
"end_character": 1012,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 1008,
"start_date_for_period": "2019-01-01",
"value": 13100000
},
{
"currency_/_unit": "USD",
"end_character": 1030,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 1026,
"start_date_for_period": "2018-01-01",
"value": 16000000
}
] |
10-Q | 0001125345-19-000112 | 20191106160806 | 20190930 | MACROGENICS INC | Revenue associated with each performance obligation was recognized as the research and development services were provided using a cost-based input method according to research and development costs incurred to date compared to estimated total research and development costs. The transfer of control occurred over this time period and, in management’s judgment, was the best measure of progress towards satisfying the performance obligation. The Company recognized $0.5 million and $1.4 million in revenue during the three and nine months ended September 30, 2018, respectively, related to the transaction price allocated to the MGD007 option. All revenue related to the upfront payment was recognized by December 31, 2018. | [
{
"currency_/_unit": "USD",
"end_character": 469,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 466,
"start_date_for_period": "2018-07-01",
"value": 500000
},
{
"currency_/_unit": "USD",
"end_character": 486,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 483,
"start_date_for_period": "2018-01-01",
"value": 1400000
}
] |
10-Q | 0001125345-19-000112 | 20191106160806 | 20190930 | MACROGENICS INC | During the three months ended September 30, 2019 and 2018, the Company recognized revenue of $4.7 million and $0.3 million, respectively, related to the flotetuzumab license grant fee. The Company recognized revenue related to the flotetuzumab license grant fee of $5.1 million and $0.9 million during the nine months ended September 30, 2019 and 2018, respectively. At September 30, 2019, $7.5 million of revenue related to the flotetuzumab license grant fee was deferred, all of which was current. At December 31, 2018, $12.6 million of revenue related to the flotetuzumab license grant fee was deferred, $0.9 million of which was current and $11.7 million of which was non-current. | [
{
"currency_/_unit": "USD",
"end_character": 97,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 94,
"start_date_for_period": "2019-07-01",
"value": 4700000
},
{
"currency_/_unit": "USD",
"end_character": 114,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 111,
"start_date_for_period": "2018-07-01",
"value": 300000
},
{
"currency_/_unit": "USD",
"end_character": 270,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 267,
"start_date_for_period": "2019-01-01",
"value": 5100000
},
{
"currency_/_unit": "USD",
"end_character": 287,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 284,
"start_date_for_period": "2018-01-01",
"value": 900000
},
{
"currency_/_unit": "USD",
"end_character": 530,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 526,
"start_date_for_period": "2018-12-31",
"value": 12600000
},
{
"currency_/_unit": "USD",
"end_character": 614,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 611,
"start_date_for_period": "2018-01-01",
"value": 900000
},
{
"currency_/_unit": "USD",
"end_character": 653,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 649,
"start_date_for_period": "2018-12-31",
"value": 11700000
}
] |
10-Q | 0001476150-19-000012 | 20191030160545 | 20190930 | Terreno Realty Corp | The Company recorded revenues and net income for the three months ended September 30, 2019 of approximately $2.4 million and $0.9 million, respectively, and recorded revenues and net income for the nine months ended September 30, 2019 of approximately $3.8 million and $1.6 million, respectively, related to the 2019 acquisitions. | [
{
"currency_/_unit": "USD",
"end_character": 112,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 109,
"start_date_for_period": "2019-07-01",
"value": 2400000
},
{
"currency_/_unit": "USD",
"end_character": 129,
"end_date_for_period": "2019-09-30",
"label": "earnings",
"start_character": 126,
"start_date_for_period": "2019-07-01",
"value": 900000
},
{
"currency_/_unit": "USD",
"end_character": 256,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 253,
"start_date_for_period": "2019-01-01",
"value": 3800000
},
{
"currency_/_unit": "USD",
"end_character": 273,
"end_date_for_period": "2019-09-30",
"label": "earnings",
"start_character": 270,
"start_date_for_period": "2019-01-01",
"value": 1600000
}
] |
10-Q | 0001476150-19-000012 | 20191030160545 | 20190930 | Terreno Realty Corp | The Company recorded revenues and net income for the three months ended September 30, 2018 of approximately $1.2 million and $0.4 million, respectively, and recorded revenues and net income for the nine months ended September 30, 2018 of approximately $2.3 million and $0.8 million, respectively, related to the 2018 acquisitions. | [
{
"currency_/_unit": "USD",
"end_character": 112,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 109,
"start_date_for_period": "2018-07-01",
"value": 1200000
},
{
"currency_/_unit": "USD",
"end_character": 129,
"end_date_for_period": "2018-09-30",
"label": "earnings",
"start_character": 126,
"start_date_for_period": "2018-07-01",
"value": 400000
},
{
"currency_/_unit": "USD",
"end_character": 256,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 253,
"start_date_for_period": "2018-01-01",
"value": 2300000
},
{
"currency_/_unit": "USD",
"end_character": 273,
"end_date_for_period": "2018-09-30",
"label": "earnings",
"start_character": 270,
"start_date_for_period": "2018-01-01",
"value": 800000
}
] |
10-Q | 0001476150-19-000012 | 20191030160545 | 20190930 | Terreno Realty Corp | In accordance with the Company’s policies of determining whether instruments granted in share-based payment transactions are participating securities and accounting for earnings per share, the net income (loss) per common share is adjusted for earnings distributed through declared dividends (if any) and allocated to all participating securities (weighted average common shares outstanding and unvested restricted shares outstanding) under the two-class method. Under this method, allocations were made to 406,970 and 374,862 of weighted average unvested restricted shares outstanding for the three months ended September 30, 2019 and 2018, respectively, and 394,089 and 363,850 of weighted average unvested restricted shares outstanding for the nine months ended September 30, 2019 and 2018, respectively. | [
{
"currency_/_unit": "shares",
"end_character": 514,
"end_date_for_period": "2019-09-30",
"label": "eps",
"start_character": 507,
"start_date_for_period": "2019-07-01",
"value": 406970
},
{
"currency_/_unit": "shares",
"end_character": 526,
"end_date_for_period": "2018-09-30",
"label": "eps",
"start_character": 519,
"start_date_for_period": "2018-07-01",
"value": 374862
},
{
"currency_/_unit": "shares",
"end_character": 667,
"end_date_for_period": "2019-09-30",
"label": "eps",
"start_character": 660,
"start_date_for_period": "2019-01-01",
"value": 394089
},
{
"currency_/_unit": "shares",
"end_character": 679,
"end_date_for_period": "2018-09-30",
"label": "eps",
"start_character": 672,
"start_date_for_period": "2018-01-01",
"value": 363850
}
] |
10-Q | 0001418091-19-000008 | 20191029192017 | 20190930 | TWITTER, INC. | Since the Company expects to settle the principal amount of the outstanding Notes in cash, the Company uses the treasury stock method for calculating any potential dilutive effect of the conversion spread on diluted net income per share, if applicable. For the 2021 Notes, the conversion spread of 24.3 million shares will have a dilutive impact on diluted net income per share of common stock when the average market price of the Company’s common stock for a given period exceeds the conversion price of $77.64 per share. For the 2024 Notes, the conversion spread of 20.1 million shares will have a dilutive impact on diluted net income per share of common stock when the average market price of the Company’s common stock for a given period exceeds the conversion price of $57.14 per share. | [
{
"currency_/_unit": "shares",
"end_character": 302,
"end_date_for_period": "2019-09-30",
"label": "eps",
"start_character": 298,
"start_date_for_period": "2019-01-01",
"value": 24300000
},
{
"currency_/_unit": null,
"end_character": 511,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 506,
"start_date_for_period": "2019-09-30",
"value": 77.64
},
{
"currency_/_unit": "shares",
"end_character": 572,
"end_date_for_period": "2019-09-30",
"label": "eps",
"start_character": 568,
"start_date_for_period": "2019-01-01",
"value": 20100000
},
{
"currency_/_unit": null,
"end_character": 781,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 776,
"start_date_for_period": "2019-09-30",
"value": 57.14
}
] |
10-Q | 0001647088-19-000050 | 20191108113802 | 20190930 | WillScot Corp | Includes $4.0 million and $3.0 million of VAPS service revenue for the three months ended September 30, 2019 and 2018, respectively, and $11.9 million and $7.9 million of VAPS service revenue for the nine months ended September 30, 2019 and 2018, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 13,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 10,
"start_date_for_period": "2019-07-01",
"value": 4000000
},
{
"currency_/_unit": "USD",
"end_character": 30,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 27,
"start_date_for_period": "2018-07-01",
"value": 3000000
},
{
"currency_/_unit": "USD",
"end_character": 142,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 138,
"start_date_for_period": "2019-01-01",
"value": 11900000
},
{
"currency_/_unit": "USD",
"end_character": 159,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 156,
"start_date_for_period": "2018-01-01",
"value": 7900000
}
] |
10-Q | 0001735828-19-000038 | 20191112172427 | 20190930 | Legacy Reserves Inc. | For the nine months ended September 30, 2019 and 2018 we recorded income/(loss) before income taxes of $(277,377) and $(31,063) respectively. All of Legacy's income is sourced within the United States. The effective combined U.S. federal and state income tax rates were 0.00% and negative 10.03% for the nine months ended September 30, 2019 and 2018, respectively. During the nine months ended September 30, 2019, the Legacy Inc. has recorded a full valuation allowance against its deferred tax position. A valuation allowance has been recorded as management does not believe that it is more-likely-than-not that its deferred tax assets will be realized. | [
{
"currency_/_unit": "USD",
"end_character": 112,
"end_date_for_period": "2019-09-30",
"label": "earnings",
"start_character": 105,
"start_date_for_period": "2019-01-01",
"value": -277377000
},
{
"currency_/_unit": "USD",
"end_character": 126,
"end_date_for_period": "2018-09-30",
"label": "earnings",
"start_character": 120,
"start_date_for_period": "2018-01-01",
"value": -31063000
},
{
"currency_/_unit": "pure",
"end_character": 274,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 270,
"start_date_for_period": "2019-01-01",
"value": 0
},
{
"currency_/_unit": "pure",
"end_character": 294,
"end_date_for_period": "2018-09-30",
"label": "XBRL-OOS",
"start_character": 289,
"start_date_for_period": "2018-01-01",
"value": 0.1003
}
] |
10-Q | 0001628280-19-014913 | 20191210162854 | 20191031 | ASPEN GROUP, INC. | The Company reported an operating loss of $(331,775) during the Fiscal 2020 Q2 as compared to $(2,474,649) for the Fiscal 2019 Q2, a decrease in the loss of $2,142,874, or 87% improvement. | [
{
"currency_/_unit": "USD",
"end_character": 51,
"end_date_for_period": "2019-10-31",
"label": "ebit",
"start_character": 44,
"start_date_for_period": "2019-08-01",
"value": -331775
}
] |
10-Q | 0001628280-19-014913 | 20191210162854 | 20191031 | ASPEN GROUP, INC. | Net loss applicable to stockholders was $(638,168), or net loss per share of $(0.03) for the Fiscal 2020 Q2 as compared to $(2,475,078) for the Fiscal 2019 Q2, a decrease in the loss of $1,836,910, or 74% improvement. | [
{
"currency_/_unit": "USD",
"end_character": 49,
"end_date_for_period": "2019-10-31",
"label": "earnings",
"start_character": 42,
"start_date_for_period": "2019-08-01",
"value": -638168
},
{
"currency_/_unit": "USD",
"end_character": 134,
"end_date_for_period": "2018-10-31",
"label": "earnings",
"start_character": 125,
"start_date_for_period": "2018-08-01",
"value": -2475078
}
] |
10-Q | 0001628280-19-014913 | 20191210162854 | 20191031 | ASPEN GROUP, INC. | The Company reported an operating loss of $(1,970,575) during the six months ended October 31, 2019 as compared to $(5,327,973) for the six months ended October 31, 2018, a decrease in the loss of $3,357,398, or 63% improvement. | [
{
"currency_/_unit": "USD",
"end_character": 53,
"end_date_for_period": "2019-10-31",
"label": "ebit",
"start_character": 44,
"start_date_for_period": "2019-05-01",
"value": -1970575
},
{
"currency_/_unit": "USD",
"end_character": 126,
"end_date_for_period": "2018-10-31",
"label": "ebit",
"start_character": 117,
"start_date_for_period": "2018-05-01",
"value": -5327973
}
] |
10-Q | 0001628280-19-014913 | 20191210162854 | 20191031 | ASPEN GROUP, INC. | Net loss applicable to stockholders was $(2,713,450), or net loss per share of $(0.14) for the six months ended October 31, 2019 as compared to $(5,312,354) for the six months ended October 31, 2018, a decrease in loss of $2,598,904, or 49% improvement. | [
{
"currency_/_unit": "USD",
"end_character": 51,
"end_date_for_period": "2019-10-31",
"label": "earnings",
"start_character": 42,
"start_date_for_period": "2019-05-01",
"value": -2713450
},
{
"currency_/_unit": null,
"end_character": 85,
"end_date_for_period": "2019-10-31",
"label": "eps",
"start_character": 81,
"start_date_for_period": "2019-05-01",
"value": -0.14
},
{
"currency_/_unit": "USD",
"end_character": 155,
"end_date_for_period": "2018-10-31",
"label": "earnings",
"start_character": 146,
"start_date_for_period": "2018-05-01",
"value": -5312354
}
] |
10-Q | 0001628280-19-014913 | 20191210162854 | 20191031 | ASPEN GROUP, INC. | Net cash used in operating activities for the six months ended October 31, 2018 totaled $(5,487,423) and resulted primarily from the net loss of $(5,312,354), partially offset by $1,838,637 in non-cash items and $2,013,706 decrease in operating assets | [
{
"currency_/_unit": "USD",
"end_character": 99,
"end_date_for_period": "2018-10-31",
"label": "XBRL-OOS",
"start_character": 90,
"start_date_for_period": "2018-05-01",
"value": -5487423
},
{
"currency_/_unit": "USD",
"end_character": 156,
"end_date_for_period": "2018-10-31",
"label": "earnings",
"start_character": 147,
"start_date_for_period": "2018-05-01",
"value": -5312354
}
] |
10-Q | 0001378453-19-000054 | 20191105110333 | 20190930 | TravelCenters of America Inc. /MD/ | Reflects the retrospective adjustment related to the reverse stock split completed on August 1, 2019, and excludes unvested shares of common stock awarded under our share award plans, which shares of common stock are considered participating securities because they participate equally in earnings and losses with all of our other shares of common stock. The weighted average number of unvested shares of common stock outstanding for the three months ended September 30, 2019 and 2018, was 309 and 274, respectively. The weighted average number of unvested shares of common stock outstanding for the nine months ended September 30, 2019 and 2018, was 313 and 358, respectively. | [
{
"currency_/_unit": "shares",
"end_character": 493,
"end_date_for_period": "2019-09-30",
"label": "eps",
"start_character": 490,
"start_date_for_period": "2019-07-01",
"value": 309000
},
{
"currency_/_unit": "shares",
"end_character": 501,
"end_date_for_period": "2018-09-30",
"label": "eps",
"start_character": 498,
"start_date_for_period": "2018-07-01",
"value": 274000
},
{
"currency_/_unit": "shares",
"end_character": 654,
"end_date_for_period": "2019-09-30",
"label": "eps",
"start_character": 651,
"start_date_for_period": "2019-01-01",
"value": 313000
},
{
"currency_/_unit": "shares",
"end_character": 662,
"end_date_for_period": "2018-09-30",
"label": "eps",
"start_character": 659,
"start_date_for_period": "2018-01-01",
"value": 358000
}
] |
10-Q | 0001479094-19-000025 | 20191030160919 | 20190930 | STAG Industrial, Inc. | During the three and nine months ended September 30, 2019 and 2018, there were 220,284, 218,231, 193,117 and 196,871, respectively, of unvested restricted shares of common stock on a weighted average basis that were considered participating securities. | [
{
"currency_/_unit": "shares",
"end_character": 86,
"end_date_for_period": "2019-09-30",
"label": "eps",
"start_character": 79,
"start_date_for_period": "2019-07-01",
"value": 220284
},
{
"currency_/_unit": "shares",
"end_character": 95,
"end_date_for_period": "2019-09-30",
"label": "eps",
"start_character": 88,
"start_date_for_period": "2019-01-01",
"value": 218231
},
{
"currency_/_unit": "shares",
"end_character": 104,
"end_date_for_period": "2018-09-30",
"label": "eps",
"start_character": 97,
"start_date_for_period": "2018-07-01",
"value": 193117
},
{
"currency_/_unit": "shares",
"end_character": 116,
"end_date_for_period": "2018-09-30",
"label": "eps",
"start_character": 109,
"start_date_for_period": "2018-01-01",
"value": 196871
}
] |
10-Q | 0001486159-19-000040 | 20191106161022 | 20190930 | Oasis Petroleum Inc. | The Company’s effective tax rate for the three and nine months ended September 30, 2019 was (134.3)% on a pre-tax income of $12.9 million and 25.0% on a pre-tax loss of $35.3 million, respectively, as compared to an effective tax rate of 27.2% on a pre-tax income of $91.0 million and 23.4% on a pre-tax loss of $321.8 million for the three and nine months ended September 30, 2018, respectively. | [
{
"currency_/_unit": "pure",
"end_character": 98,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 93,
"start_date_for_period": "2019-07-01",
"value": -1.343
},
{
"currency_/_unit": "USD",
"end_character": 129,
"end_date_for_period": "2019-09-30",
"label": "earnings",
"start_character": 125,
"start_date_for_period": "2019-07-01",
"value": 12900000
},
{
"currency_/_unit": "pure",
"end_character": 146,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 142,
"start_date_for_period": "2019-01-01",
"value": 0.25
},
{
"currency_/_unit": "USD",
"end_character": 174,
"end_date_for_period": "2019-09-30",
"label": "earnings",
"start_character": 170,
"start_date_for_period": "2019-01-01",
"value": -35300000
},
{
"currency_/_unit": "pure",
"end_character": 242,
"end_date_for_period": "2018-09-30",
"label": "XBRL-OOS",
"start_character": 238,
"start_date_for_period": "2018-07-01",
"value": 0.272
},
{
"currency_/_unit": "USD",
"end_character": 272,
"end_date_for_period": "2018-09-30",
"label": "earnings",
"start_character": 268,
"start_date_for_period": "2018-07-01",
"value": 91000000
},
{
"currency_/_unit": "pure",
"end_character": 289,
"end_date_for_period": "2018-09-30",
"label": "XBRL-OOS",
"start_character": 285,
"start_date_for_period": "2018-01-01",
"value": 0.234
},
{
"currency_/_unit": "USD",
"end_character": 318,
"end_date_for_period": "2018-09-30",
"label": "earnings",
"start_character": 313,
"start_date_for_period": "2018-01-01",
"value": -321800000
}
] |
10-Q | 0001628280-19-013886 | 20191112081145 | 20190930 | Teligent, Inc. | For the three months ended September 30, 2019, domestic net revenues were $13.4 million and foreign net revenues were $5.1 million. For the nine months ended September 30, 2019, domestic net revenues were $36.5 million and foreign net revenues were $13.4 million. As of September 30, 2019, domestic assets were $142.5 million and foreign assets were $53.7 million. For the three months ended September 30, 2018, domestic net revenues were $13.3 million and foreign net revenues were $5.0 million. For the nine months ended September 30, 2018, domestic net revenues were $34.9 million and foreign net revenues were $14.2 million. As of September 30, 2018, domestic assets were $131.9 million and foreign assets were $61.0 million. | [
{
"currency_/_unit": "USD",
"end_character": 79,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 75,
"start_date_for_period": "2019-07-01",
"value": 13400000
},
{
"currency_/_unit": "USD",
"end_character": 122,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 119,
"start_date_for_period": "2019-07-01",
"value": 5100000
},
{
"currency_/_unit": "USD",
"end_character": 210,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 206,
"start_date_for_period": "2019-01-01",
"value": 36500000
},
{
"currency_/_unit": "USD",
"end_character": 254,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 250,
"start_date_for_period": "2019-07-01",
"value": 13400000
},
{
"currency_/_unit": "USD",
"end_character": 317,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 312,
"start_date_for_period": "2019-09-30",
"value": 142500000
},
{
"currency_/_unit": "USD",
"end_character": 355,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 351,
"start_date_for_period": "2019-09-30",
"value": 53700000
},
{
"currency_/_unit": "USD",
"end_character": 444,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 440,
"start_date_for_period": "2018-07-01",
"value": 13300000
},
{
"currency_/_unit": "USD",
"end_character": 487,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 484,
"start_date_for_period": "2018-07-01",
"value": 5000000
},
{
"currency_/_unit": "USD",
"end_character": 576,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 572,
"start_date_for_period": "2018-01-01",
"value": 34900000
},
{
"currency_/_unit": "USD",
"end_character": 620,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 616,
"start_date_for_period": "2018-01-01",
"value": 14200000
},
{
"currency_/_unit": "USD",
"end_character": 684,
"end_date_for_period": "2018-09-30",
"label": "XBRL-OOS",
"start_character": 679,
"start_date_for_period": "2018-09-30",
"value": 131900000
},
{
"currency_/_unit": "USD",
"end_character": 722,
"end_date_for_period": "2018-09-30",
"label": "XBRL-OOS",
"start_character": 718,
"start_date_for_period": "2018-09-30",
"value": 61000000
}
] |
10-Q | 0001640334-19-002090 | 20191021181130 | 20190831 | Wari, Inc. | The accompanying unaudited condensed financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of August 31, 2019, the Company has a loss from operations of $158,951, and an accumulated deficit of $422,336. The Company is seeking a new business opportunity at this time. If and when it acquires such an opportunity, it might be required to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the period of 12 months from the issuance of those financial statements. | [
{
"currency_/_unit": "USD",
"end_character": 324,
"end_date_for_period": "2019-08-31",
"label": "earnings",
"start_character": 317,
"start_date_for_period": "2018-12-01",
"value": -158951
},
{
"currency_/_unit": "USD",
"end_character": 364,
"end_date_for_period": "2019-08-31",
"label": "XBRL-OOS",
"start_character": 357,
"start_date_for_period": "2019-08-31",
"value": -422336
}
] |
10-Q | 0001640334-19-002090 | 20191021181130 | 20190831 | Wari, Inc. | The accompanying unaudited condensed financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of August 31, 2019, the Company has a loss from operations of $158,951, and an accumulated deficit of $422,336. The Company is seeking a new business opportunity at this time. If and when it acquires such an opportunity, it might be required to fund operations through equity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the period of 12 months from the issuance of those financial statements. | [
{
"currency_/_unit": "USD",
"end_character": 324,
"end_date_for_period": "2019-08-31",
"label": "earnings",
"start_character": 317,
"start_date_for_period": "2018-12-01",
"value": -158951
},
{
"currency_/_unit": "USD",
"end_character": 364,
"end_date_for_period": "2019-08-31",
"label": "XBRL-OOS",
"start_character": 357,
"start_date_for_period": "2019-08-31",
"value": -422336
}
] |
10-Q | 0001714973-19-000050 | 20191023180402 | 20190930 | Kinder Morgan Canada Ltd | For the three and nine months ended September 30, 2019, the weighted average maximum number of potential Restricted Voting Share equivalents of 0.3 million and 0.2 million, respectively, of unvested RSU awards are antidilutive and, accordingly, are excluded from the determination of diluted earnings per Restricted Voting Share. | [
{
"currency_/_unit": "shares",
"end_character": 147,
"end_date_for_period": "2019-09-30",
"label": "eps",
"start_character": 144,
"start_date_for_period": "2019-07-01",
"value": 300000
},
{
"currency_/_unit": "shares",
"end_character": 163,
"end_date_for_period": "2019-09-30",
"label": "eps",
"start_character": 160,
"start_date_for_period": "2019-01-01",
"value": 200000
}
] |
10-Q | 0001714973-19-000050 | 20191023180402 | 20190930 | Kinder Morgan Canada Ltd | Lease income for the three and nine months ended September 30, 2019 totaled $6.8 million and $18.9 million, respectively, including variable lease payments that are excluded from the following disclosure as the amounts cannot be reasonably estimated for future periods. | [
{
"currency_/_unit": "CAD",
"end_character": 80,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 77,
"start_date_for_period": "2019-07-01",
"value": 6800000
},
{
"currency_/_unit": "CAD",
"end_character": 98,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 94,
"start_date_for_period": "2019-01-01",
"value": 18900000
}
] |
10-Q | 0001408075-19-000039 | 20191022135107 | 20190930 | GRAPHIC PACKAGING HOLDING CO | The year over year Net Sales and Loss from Operations impact for Letica Foodservice, PFP and Artistic acquisitions were $96.0 million and $8.3 million, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 125,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 121,
"start_date_for_period": "2019-01-01",
"value": 96000000
},
{
"currency_/_unit": "USD",
"end_character": 142,
"end_date_for_period": "2019-09-30",
"label": "ebit",
"start_character": 139,
"start_date_for_period": "2019-01-01",
"value": -8300000.000000001
}
] |
10-Q | 0001408075-19-000039 | 20191022135107 | 20190930 | GRAPHIC PACKAGING HOLDING CO | During the nine months ended September 30, 2019, the Company recognized Income Tax Expense of $60.9 million on Income before Income Taxes and Equity Income of Unconsolidated Entity of $294.6 million. The effective tax rate for the nine months ended September 30, 2019 is lower than the statutory rate primarily due to the tax effect of income attributable to noncontrolling interests as well as the mix and levels of earnings between foreign and domestic tax jurisdictions. | [
{
"currency_/_unit": "USD",
"end_character": 99,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 95,
"start_date_for_period": "2019-01-01",
"value": 60900000
},
{
"currency_/_unit": "USD",
"end_character": 190,
"end_date_for_period": "2019-09-30",
"label": "earnings",
"start_character": 185,
"start_date_for_period": "2019-01-01",
"value": 294600000
}
] |
10-Q | 0000008868-19-000049 | 20191031065526 | 20190930 | AVON PRODUCTS INC | * 2019 includes the impact of certain Brazil indirect taxes which was recorded in product sales of approximately $68, in our Consolidated Income Statements. See Note 14 Supplemental Balance Sheet Information, to the Consolidated Financial Statements contained herein for further information. 2018 includes the impact of the Brazil IPI, which was recorded in product sales of approximately $168, in our Consolidated Income Statements. See Note 11, Contingencies, to the Consolidated Financial Statements contained herein for further information. | [
{
"currency_/_unit": "USD",
"end_character": 116,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 114,
"start_date_for_period": "2019-01-01",
"value": 68000000
},
{
"currency_/_unit": "USD",
"end_character": 393,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 390,
"start_date_for_period": "2018-01-01",
"value": 168000000
}
] |
10-Q | 0001104506-19-000026 | 20191030073128 | 20190930 | INSMED Inc | The Company had $535.6 million in cash and cash equivalents as of September 30, 2019 and reported a net loss of $201.3 million for the nine months ended September 30, 2019. Historically, the Company has funded its operations through public offerings of equity securities and debt financings. The Company commenced commercial shipments of ARIKAYCE in October 2018. The Company expects to continue to incur operating losses both at its US and certain international entities while funding research and development (R&D) activities for ARIKAYCE and its other pipeline programs, continuing commercial launch activities for ARIKAYCE in the US, continuing to invest in pre-commercial and regulatory activities for ARIKAYCE in Europe and Japan, and funding other general and administrative activities. | [
{
"currency_/_unit": "USD",
"end_character": 22,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 17,
"start_date_for_period": "2019-09-30",
"value": 535600000
},
{
"currency_/_unit": "USD",
"end_character": 118,
"end_date_for_period": "2019-09-30",
"label": "earnings",
"start_character": 113,
"start_date_for_period": "2019-01-01",
"value": -201300000
}
] |
10-Q | 0001628280-19-012903 | 20191031073937 | 20190930 | MGP INGREDIENTS INC | Participating securities included 112,865 and 331,375 unvested restricted stock units (“RSUs”), at September 30, 2019 and 2018, respectively. | [
{
"currency_/_unit": "shares",
"end_character": 41,
"end_date_for_period": "2019-09-30",
"label": "eps",
"start_character": 34,
"start_date_for_period": "2019-01-01",
"value": 112865
},
{
"currency_/_unit": "shares",
"end_character": 53,
"end_date_for_period": "2018-09-30",
"label": "eps",
"start_character": 46,
"start_date_for_period": "2018-01-01",
"value": 331375
}
] |
10-Q | 0001318568-19-000143 | 20191105161228 | 20190930 | Everi Holdings Inc. | Equipment revenues are derived from the sale of our cash access kiosks and related equipment and are accounted for under ASC 606, unless such transactions meet definition of a sales type or direct financing lease which are accounted for under ASC 842. Revenues are recognized at a point in time when control of the promised goods and services transfers to the customer generally upon shipment or delivery pursuant to the terms of the contract. The sales contracts are generally short-term in nature with payment terms ranging from 30 to 90 days, while certain agreements provide for extended payment terms of up to 60 months. Each contract containing extended payment terms over a period of 12 months is evaluated for the presence of a financing component. For those arrangements in which the financing component is determined to be significant to the contract, the transaction price is adjusted for the time value of money. Generally, our contracts with customers do not contain a financing component that has been determined to be significant to the contract. The cash access kiosk and related equipment sales contracts accounted for under ASC 842 were approximately $0.1 million and $2.7 million in aggregate revenue for the three and nine months ended September 30, 2019, respectively. We did not have any cash access kiosk and related equipment sales transactions that qualified for sales type lease accounting treatment in 2018. | [
{
"currency_/_unit": "USD",
"end_character": 1173,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 1170,
"start_date_for_period": "2019-07-01",
"value": 100000
},
{
"currency_/_unit": "USD",
"end_character": 1190,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 1187,
"start_date_for_period": "2019-01-01",
"value": 2700000
}
] |
10-Q | 0001336917-19-000075 | 20191108160803 | 20190930 | Under Armour, Inc. | In addition to the investment in Dome, the Company has a license agreement with Dome. The Company recorded license revenues from Dome of $9.2 million and $9.2 million for the three months ended September 30, 2019 and 2018, respectively, and $20.9 million and $22.9 million for the nine months ended September 30, 2019 and 2018, respectively. As of September 30, 2019, December 31, 2018, and September 30, 2018, the Company had $9.1 million, $13.1 million, and $9.0 million, respectively, in licensing receivables outstanding, recorded in the prepaid expenses and other current assets line item within the Company's unaudited consolidated balance sheets. | [
{
"currency_/_unit": "USD",
"end_character": 141,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 138,
"start_date_for_period": "2019-07-01",
"value": 9200000
},
{
"currency_/_unit": "USD",
"end_character": 158,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 155,
"start_date_for_period": "2019-07-01",
"value": 9200000
},
{
"currency_/_unit": "USD",
"end_character": 246,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 242,
"start_date_for_period": "2019-01-01",
"value": 20900000
},
{
"currency_/_unit": "USD",
"end_character": 264,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 260,
"start_date_for_period": "2018-01-01",
"value": 22900000
},
{
"currency_/_unit": "USD",
"end_character": 431,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 428,
"start_date_for_period": "2019-09-30",
"value": 9100000
},
{
"currency_/_unit": "USD",
"end_character": 446,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 442,
"start_date_for_period": "2018-12-31",
"value": 13100000
},
{
"currency_/_unit": "USD",
"end_character": 464,
"end_date_for_period": "2018-09-30",
"label": "XBRL-OOS",
"start_character": 461,
"start_date_for_period": "2018-09-30",
"value": 9000000
}
] |
10-K | 0000008063-20-000013 | 20200302120629 | 20191231 | ASTRONICS CORP | Stock options with exercise prices greater than the average market price of the underlying common shares are excluded from the computation of diluted earnings per share because they are out-of-the-money and the effect of their inclusion would be anti-dilutive. The number of common shares excluded from the computation was approximately 0.5 million for the year ended December 31, 2019, 0.2 million for the year ended December 31, 2018, and 0.1 million for the year ended December 31, 2017. | [
{
"currency_/_unit": "shares",
"end_character": 340,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 337,
"start_date_for_period": "2019-01-01",
"value": 500000
},
{
"currency_/_unit": "shares",
"end_character": 390,
"end_date_for_period": "2018-12-31",
"label": "eps",
"start_character": 387,
"start_date_for_period": "2018-01-01",
"value": 200000
},
{
"currency_/_unit": "shares",
"end_character": 444,
"end_date_for_period": "2017-12-31",
"label": "eps",
"start_character": 441,
"start_date_for_period": "2017-01-01",
"value": 100000
}
] |
10-K | 0000008868-20-000009 | 20200305163340 | 20191231 | AVON PRODUCTS INC | This new guidance requires entities to (1) disaggregate the service cost component from the other components of net periodic benefit costs and present it with other current employee compensation costs in the Consolidated Statements of Operations and (2) present the other components of net periodic benefit costs below operating profit in other expense, net. We adopted this new accounting guidance effective January 1, 2018. The new accounting guidance was applied retrospectively and increased our operating profit for 2017 and 2016 by $8.0 and $1.9 respectively, but had no impact on net loss. | [
{
"currency_/_unit": "USD",
"end_character": 542,
"end_date_for_period": "2017-12-31",
"label": "ebit",
"start_character": 539,
"start_date_for_period": "2017-01-01",
"value": 8000000
},
{
"currency_/_unit": "USD",
"end_character": 551,
"end_date_for_period": "2016-12-31",
"label": "ebit",
"start_character": 548,
"start_date_for_period": "2016-01-01",
"value": 1900000
}
] |
10-K | 0000008868-20-000009 | 20200305163340 | 20191231 | AVON PRODUCTS INC | 2019 includes the impact of certain Brazil indirect taxes which was recorded in product sales of approximately $68, in our Consolidated Income Statements. See Note 21 Supplemental Balance Sheet Information, to the Consolidated Financial Statements contained herein for further information. 2018 includes the impact of the Brazil IPI, which was recorded in product sales, of approximately $168, in our Consolidated Income Statements. See Note 19, Contingencies, to the Consolidated Financial Statements contained herein for further information. | [
{
"currency_/_unit": "USD",
"end_character": 114,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 112,
"start_date_for_period": "2019-01-01",
"value": 68000000
},
{
"currency_/_unit": "USD",
"end_character": 392,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 389,
"start_date_for_period": "2018-01-01",
"value": 168000000
}
] |
10-K | 0000027419-20-000008 | 20200311161426 | 20200201 | TARGET CORP | Earnings from continuing operations before income taxes were $4,190 million, $3,676 million, and $3,630 million during 2019, 2018, and 2017, respectively, including $653 million, $565 million, and $566 million earned by our foreign entities subject to tax outside of the U.S. During 2019, we reached an agreement with the IRS on certain tax positions related to our global sourcing operations, and as a result, we reclassified $169 million and $156 million of previously disclosed 2018 and 2017 earnings, respectively, from foreign to domestic to conform to the current period classification. | [
{
"currency_/_unit": "USD",
"end_character": 67,
"end_date_for_period": "2020-02-01",
"label": "earnings",
"start_character": 62,
"start_date_for_period": "2019-02-03",
"value": 4190000000
},
{
"currency_/_unit": "USD",
"end_character": 83,
"end_date_for_period": "2019-02-02",
"label": "earnings",
"start_character": 78,
"start_date_for_period": "2018-02-04",
"value": 3676000000
},
{
"currency_/_unit": "USD",
"end_character": 103,
"end_date_for_period": "2018-02-03",
"label": "earnings",
"start_character": 98,
"start_date_for_period": "2017-01-29",
"value": 3630000000
},
{
"currency_/_unit": "USD",
"end_character": 169,
"end_date_for_period": "2020-02-01",
"label": "XBRL-OOS",
"start_character": 166,
"start_date_for_period": "2019-02-03",
"value": 653000000
},
{
"currency_/_unit": "USD",
"end_character": 183,
"end_date_for_period": "2019-02-02",
"label": "XBRL-OOS",
"start_character": 180,
"start_date_for_period": "2018-02-04",
"value": 565000000
},
{
"currency_/_unit": "USD",
"end_character": 201,
"end_date_for_period": "2018-02-03",
"label": "XBRL-OOS",
"start_character": 198,
"start_date_for_period": "2017-01-29",
"value": 566000000
}
] |
10-K | 0000029989-20-000005 | 20200211164807 | 20191231 | OMNICOM GROUP INC. | The Americas is comprised of North America, which includes the United States, Canada and Puerto Rico, and Latin America, which includes South America and Mexico. EMEA is comprised of Europe, the Middle East and Africa. Asia-Pacific includes Australia, Greater China, India, Japan, Korea, New Zealand, Singapore and other Asian countries. Revenue in the United States in 2019 and 2018 was $8,033.0 million and $7,999.8 million, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 396,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 389,
"start_date_for_period": "2019-01-01",
"value": 8033000000
},
{
"currency_/_unit": "USD",
"end_character": 417,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 410,
"start_date_for_period": "2018-01-01",
"value": 7999800000
}
] |
10-K | 0000052795-20-000037 | 20200220155410 | 20200103 | ANIXTER INTERNATIONAL INC | The Company had 0.2 million, 0.3 million, and 0.4 million in 2019, 2018 and 2017, respectively, of additional shares related to stock options and stock units included in the computation of diluted earnings per share because the effect of those common stock equivalents were dilutive during these periods. Antidilutive stock options and units are excluded from the calculation of weighted-average shares for diluted earnings per share. For 2019, 2018 and 2017, the antidilutive stock options and units were immaterial. | [
{
"currency_/_unit": "shares",
"end_character": 19,
"end_date_for_period": "2020-01-03",
"label": "eps",
"start_character": 16,
"start_date_for_period": "2018-12-29",
"value": 200000
},
{
"currency_/_unit": "shares",
"end_character": 32,
"end_date_for_period": "2018-12-28",
"label": "eps",
"start_character": 29,
"start_date_for_period": "2017-12-30",
"value": 300000
},
{
"currency_/_unit": "shares",
"end_character": 49,
"end_date_for_period": "2017-12-29",
"label": "eps",
"start_character": 46,
"start_date_for_period": "2016-12-31",
"value": 400000
}
] |
10-K | 0000052795-20-000037 | 20200220155410 | 20200103 | ANIXTER INTERNATIONAL INC | The Company attributes foreign sales based on the location of the customer purchasing the product. In North America (U.S. and Canada), sales in the U.S. were $6,294.6 million, $6,004.7 million and $5,771.5 million in 2019, 2018 and 2017, respectively. Canadian sales were $858.0 million, $837.4 million and $772.5 million in 2019, 2018 and 2017 respectively. No other individual foreign country’s net sales within EMEA or the Emerging Markets were material in 2019, 2018 and 2017. The Company's tangible long-lived assets primarily consist of $147.9 million of property and equipment in the U.S. No other individual foreign country’s tangible long-lived assets are material. | [
{
"currency_/_unit": "USD",
"end_character": 166,
"end_date_for_period": "2020-01-03",
"label": "revenues",
"start_character": 159,
"start_date_for_period": "2018-12-29",
"value": 6294600000
},
{
"currency_/_unit": "USD",
"end_character": 184,
"end_date_for_period": "2018-12-28",
"label": "revenues",
"start_character": 177,
"start_date_for_period": "2017-12-30",
"value": 6004700000
},
{
"currency_/_unit": "USD",
"end_character": 205,
"end_date_for_period": "2017-12-29",
"label": "revenues",
"start_character": 198,
"start_date_for_period": "2016-12-31",
"value": 5771500000
},
{
"currency_/_unit": "USD",
"end_character": 278,
"end_date_for_period": "2020-01-03",
"label": "revenues",
"start_character": 273,
"start_date_for_period": "2018-12-29",
"value": 858000000
},
{
"currency_/_unit": "USD",
"end_character": 294,
"end_date_for_period": "2018-12-28",
"label": "revenues",
"start_character": 289,
"start_date_for_period": "2017-12-30",
"value": 837400000
},
{
"currency_/_unit": "USD",
"end_character": 313,
"end_date_for_period": "2017-12-29",
"label": "revenues",
"start_character": 308,
"start_date_for_period": "2016-12-31",
"value": 772500000
},
{
"currency_/_unit": "USD",
"end_character": 549,
"end_date_for_period": "2020-01-03",
"label": "XBRL-OOS",
"start_character": 544,
"start_date_for_period": "2020-01-03",
"value": 147900000
}
] |
10-K | 0000091440-20-000004 | 20200213164210 | 20191228 | Snap-on Inc | In general, it is Snap-on’s practice and intention to reinvest certain earnings of its non-U.S. subsidiaries in those operations. As of 2019 year end, the company has not made a provision for incremental U.S. income taxes or additional foreign withholding taxes on approximately $271.8 million of such undistributed earnings that is deemed indefinitely reinvested. Determination of the amount of unrecognized deferred tax liability related to these earnings is not practicable. As a result of the Tax Act, which subjected the majority of the company’s undistributed foreign earnings to taxation for the 2017 tax year, the company can now repatriate non-U.S. cash in a tax efficient manner. Accordingly, the company has reversed its prior assertion concerning the indefinite reinvestment of the majority of its undistributed foreign earnings and has recorded a deferred tax liability of $6.6 million for the incremental tax costs associated with the future potential repatriation of such earnings. | [
{
"currency_/_unit": "USD",
"end_character": 285,
"end_date_for_period": "2019-12-28",
"label": "eps",
"start_character": 280,
"start_date_for_period": "2018-12-30",
"value": 271800000
},
{
"currency_/_unit": "USD",
"end_character": 892,
"end_date_for_period": "2019-12-28",
"label": "XBRL-OOS",
"start_character": 889,
"start_date_for_period": "2019-12-28",
"value": 6600000
}
] |
10-K | 0000109380-20-000092 | 20200225201550 | 20191231 | ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ | The Bank enters into certain lease agreements where it is the lessor of real estate. Real estate leases are made from bank-owned and subleased property to generate cash flow from the property, including from leasing vacant suites in which the Bank occupies portions of the building. Operating lease income was $12 million and $11 million for the years ending 2019 and 2018, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 313,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 311,
"start_date_for_period": "2019-01-01",
"value": 12000000
},
{
"currency_/_unit": "USD",
"end_character": 329,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 327,
"start_date_for_period": "2018-01-01",
"value": 11000000
}
] |
10-K | 0000320335-20-000008 | 20200227161253 | 20191231 | GLOBE LIFE INC. | Premium income for traditional long-duration life and health insurance products is recognized evenly over the contract period and when due from the policyholder. Premiums for short-duration health contracts are recognized as revenue over the contract period in proportion to the insurance protection provided. Premiums for universal life-type and annuity contracts are added to the policy account value, and revenues for such products are recognized as charges to the policy account value for mortality, administration, and surrenders (retrospective deposit method). Life premium includes policy charges of $15.6 million, $16.4 million and $17.0 million for the years ended December 31, 2019, 2018, and 2017, respectively. Other | [
{
"currency_/_unit": "USD",
"end_character": 612,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 608,
"start_date_for_period": "2019-01-01",
"value": 15600000
},
{
"currency_/_unit": "USD",
"end_character": 627,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 623,
"start_date_for_period": "2018-01-01",
"value": 16399999.999999998
},
{
"currency_/_unit": "USD",
"end_character": 645,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 641,
"start_date_for_period": "2017-01-01",
"value": 17000000
}
] |
10-K | 0000320335-20-000008 | 20200227161253 | 20191231 | GLOBE LIFE INC. | Excludes policy charges of $15.6 million, $16.4 million, and $17.0 million in each of the years 2019, 2018, and 2017, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 32,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 28,
"start_date_for_period": "2019-01-01",
"value": 15600000
},
{
"currency_/_unit": "USD",
"end_character": 47,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 43,
"start_date_for_period": "2018-01-01",
"value": 16399999.999999998
},
{
"currency_/_unit": "USD",
"end_character": 66,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 62,
"start_date_for_period": "2017-01-01",
"value": 17000000
}
] |
10-K | 0000790051-20-000071 | 20200210161408 | 20191231 | CARLISLE COMPANIES INC | For the period from November 20, 2019 to December 31, 2019, Providien contributed revenues of $11.3 million and operating income of $0.1 million to the Company's consolidated results. The results of operations of the acquired business are reported as part of the CIT segment. | [
{
"currency_/_unit": "USD",
"end_character": 99,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 95,
"start_date_for_period": "2019-11-20",
"value": 11300000
},
{
"currency_/_unit": "USD",
"end_character": 136,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 133,
"start_date_for_period": "2019-11-20",
"value": 100000
}
] |
10-K | 0000790051-20-000071 | 20200210161408 | 20191231 | CARLISLE COMPANIES INC | For the period from January 11, 2019 to December 31, 2019, Petersen contributed revenues of $176.2 million and operating income of $9.8 million to the Company's consolidated results. The results of operations of the acquired business are reported as part of the CCM segment. | [
{
"currency_/_unit": "USD",
"end_character": 98,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 93,
"start_date_for_period": "2019-01-11",
"value": 176200000
},
{
"currency_/_unit": "USD",
"end_character": 135,
"end_date_for_period": "2019-12-31",
"label": "ebit",
"start_character": 132,
"start_date_for_period": "2019-01-11",
"value": 9800000
}
] |
10-K | 0000790051-20-000071 | 20200210161408 | 20191231 | CARLISLE COMPANIES INC | MicroConnex contributed revenues of $10.2 million and an operating loss of $0.8 million for the period from April 1, 2019 to December 31, 2019. The results of operations of the acquired business are reported within the CIT segment. | [
{
"currency_/_unit": "USD",
"end_character": 41,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 37,
"start_date_for_period": "2019-04-01",
"value": 10200000
},
{
"currency_/_unit": "USD",
"end_character": 79,
"end_date_for_period": "2019-12-31",
"label": "ebit",
"start_character": 76,
"start_date_for_period": "2019-04-01",
"value": -800000
}
] |
10-K | 0000790051-20-000071 | 20200210161408 | 20191231 | CARLISLE COMPANIES INC | Arbo contributed revenues of $14.0 million and operating income of $0.3 million for the period from January 31, 2017 to December 31, 2017. The results of operations of the acquired business are reported within the CCM segment. | [
{
"currency_/_unit": "USD",
"end_character": 34,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 30,
"start_date_for_period": "2019-01-31",
"value": 14000000
},
{
"currency_/_unit": "USD",
"end_character": 71,
"end_date_for_period": "2019-12-31",
"label": "ebit",
"start_character": 68,
"start_date_for_period": "2019-01-31",
"value": 300000
}
] |
10-K | 0000867773-20-000010 | 20200214194733 | 20191229 | SUNPOWER CORP | In the year ended December 29, 2019, our income tax provision of $26.6 million on a profit before income taxes and equity in earnings (losses) of unconsolidated investees of $26.0 million was primarily due to tax expense in foreign jurisdictions that were profitable. In the year ended December 30, 2018, our income tax provision of $1.0 million on a loss before income taxes and equity in earnings of unconsolidated investees of $898.7 million was primarily due to tax expense in foreign jurisdictions that were profitable, offset by tax benefit related to release of valuation allowance in a foreign jurisdiction, and by a release of tax reserves due to lapse of statutes of limitation. | [
{
"currency_/_unit": "USD",
"end_character": 70,
"end_date_for_period": "2019-12-29",
"label": "XBRL-OOS",
"start_character": 66,
"start_date_for_period": "2018-12-31",
"value": 26600000
},
{
"currency_/_unit": "USD",
"end_character": 179,
"end_date_for_period": "2019-12-29",
"label": "earnings",
"start_character": 175,
"start_date_for_period": "2018-12-31",
"value": 26000000
},
{
"currency_/_unit": "USD",
"end_character": 337,
"end_date_for_period": "2018-12-30",
"label": "XBRL-OOS",
"start_character": 334,
"start_date_for_period": "2018-01-01",
"value": 1000000
},
{
"currency_/_unit": "USD",
"end_character": 436,
"end_date_for_period": "2018-12-30",
"label": "earnings",
"start_character": 431,
"start_date_for_period": "2018-01-01",
"value": -898700000
}
] |
10-K | 0000897101-20-000134 | 20200312115354 | 20191231 | CYBEROPTICS CORP | Revenue from sales of high precision 3D and 2D sensors based on our 3D Multi-Reflection Suppression (MRS) technology was $6 million in 2019 and $7.9 million in 2018. Revenue from sales of inspection and metrology systems based on our 3D MRS sensor technology was $17.9 million in 2019 and $13.3 million in 2018. | [
{
"currency_/_unit": "USD",
"end_character": 123,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 122,
"start_date_for_period": "2019-01-01",
"value": 6000000
},
{
"currency_/_unit": "USD",
"end_character": 148,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 145,
"start_date_for_period": "2018-01-01",
"value": 7900000
},
{
"currency_/_unit": "USD",
"end_character": 268,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 264,
"start_date_for_period": "2019-01-01",
"value": 17900000
},
{
"currency_/_unit": "USD",
"end_character": 294,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 290,
"start_date_for_period": "2018-01-01",
"value": 13300000
}
] |
10-K | 0000897101-20-000134 | 20200312115354 | 20191231 | CYBEROPTICS CORP | Revenue from sales of high precision 3D and 2D sensors based on our 3D Multi-Reflection Suppression (MRS) technology was $6 million in 2019 and $7.9 million in 2018. Revenue from sales of inspection and metrology systems based on our 3D MRS sensor technology was $17.9 million in 2019 and $13.3 million in 2018. | [
{
"currency_/_unit": "USD",
"end_character": 123,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 122,
"start_date_for_period": "2019-01-01",
"value": 6000000
},
{
"currency_/_unit": "USD",
"end_character": 148,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 145,
"start_date_for_period": "2018-01-01",
"value": 7900000
},
{
"currency_/_unit": "USD",
"end_character": 268,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 264,
"start_date_for_period": "2019-01-01",
"value": 17900000
},
{
"currency_/_unit": "USD",
"end_character": 294,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 290,
"start_date_for_period": "2018-01-01",
"value": 13300000
}
] |
10-K | 0000897101-20-000134 | 20200312115354 | 20191231 | CYBEROPTICS CORP | Revenue from sales of high precision 3D and 2D sensors based on our 3D Multi-Reflection Suppression (MRS) technology was $6 million in 2019 and $7.9 million in 2018. Revenue from sales of inspection and metrology systems based on our 3D MRS sensor technology was $17.9 million in 2019 and $13.3 million in 2018. | [
{
"currency_/_unit": "USD",
"end_character": 123,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 122,
"start_date_for_period": "2019-01-01",
"value": 6000000
},
{
"currency_/_unit": "USD",
"end_character": 148,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 145,
"start_date_for_period": "2018-01-01",
"value": 7900000
},
{
"currency_/_unit": "USD",
"end_character": 268,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 264,
"start_date_for_period": "2019-01-01",
"value": 17900000
},
{
"currency_/_unit": "USD",
"end_character": 294,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 290,
"start_date_for_period": "2018-01-01",
"value": 13300000
}
] |
10-K | 0000897101-20-000148 | 20200312162146 | 20191231 | IMAGE SENSING SYSTEMS INC | We recognized royalty income from this agreement of $8.3 million and $8.9 million in 2019 and 2018, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 56,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 53,
"start_date_for_period": "2019-01-01",
"value": 8300000.000000001
},
{
"currency_/_unit": "USD",
"end_character": 73,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 70,
"start_date_for_period": "2018-01-01",
"value": 8900000
}
] |
10-K | 0000911177-20-000010 | 20200221170204 | 20191231 | CASELLA WASTE SYSTEMS INC | Payments to customers that are not in exchange for a distinct good or service are recorded as a reduction of revenues. Rebates to certain customers associated with payments for recycled or organic materials that are received and subsequently processed and sold to other third-parties amounted to $4,428 and $6,279 in fiscal year 2019 and 2018, respectively. Rebates are generally recorded as a reduction of revenues upon the sale of such materials, or upon receipt of the recycled materials at our facilities. These payments were previously recorded as a cost of operations. We did not record any revenues in fiscal year 2019 or fiscal year 2018 from performance obligations satisfied in previous periods. | [
{
"currency_/_unit": "USD",
"end_character": 302,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 297,
"start_date_for_period": "2019-01-01",
"value": -4428000
},
{
"currency_/_unit": "USD",
"end_character": 313,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 308,
"start_date_for_period": "2018-01-01",
"value": -6279000
}
] |
10-K | 0000930420-20-000033 | 20200221160643 | 20191231 | KFORCE INC | For the years ended December 31, 2019, 2018 and 2017, there were 586 thousand, 513 thousand, and 364 thousand common stock equivalents, respectively, included in the diluted WASO. For the years ended December 31, 2019, 2018 and 2017, there were 1 thousand, nil and 527 thousand, respectively, of anti-dilutive common stock equivalents. | [
{
"currency_/_unit": "shares",
"end_character": 68,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 65,
"start_date_for_period": "2019-01-01",
"value": 586000
},
{
"currency_/_unit": "shares",
"end_character": 82,
"end_date_for_period": "2018-12-31",
"label": "eps",
"start_character": 79,
"start_date_for_period": "2018-01-01",
"value": 513000
},
{
"currency_/_unit": "shares",
"end_character": 100,
"end_date_for_period": "2017-12-31",
"label": "eps",
"start_character": 97,
"start_date_for_period": "2017-01-01",
"value": 364000
},
{
"currency_/_unit": "shares",
"end_character": 211,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 210,
"start_date_for_period": "2019-01-01",
"value": 1000
},
{
"currency_/_unit": "shares",
"end_character": 268,
"end_date_for_period": "2017-12-31",
"label": "XBRL-OOS",
"start_character": 265,
"start_date_for_period": "2017-01-01",
"value": 527000
}
] |
10-K | 0001039399-20-000011 | 20200221165352 | 20191228 | FORMFACTOR INC | We acquired FRT GmbH on October 9, 2019, and we have not yet completed the process of integrating the acquired business’ internal control over financial reporting into our overall internal control over financial reporting process. Accordingly, we excluded from our assessment of internal control over financial reporting as of December 28, 2019, the internal control over financial reporting of FRT GmbH. Associated with FRT GmbH are total assets of $35.2 million, including goodwill and identified intangibles, and net revenues of $3.9 million included in our consolidated financial statements as of and for the fiscal year ended December 28, 2019. | [
{
"currency_/_unit": "USD",
"end_character": 536,
"end_date_for_period": "2019-12-28",
"label": "revenues",
"start_character": 533,
"start_date_for_period": "2019-10-09",
"value": 3900000
}
] |
10-K | 0001039399-20-000011 | 20200221165352 | 20191228 | FORMFACTOR INC | Our Consolidated Statements of Income include the financial results of FRT subsequent to the acquisition date of October 9, 2019. Revenue related to FRT since the acquisition date that was included in our Consolidated Statements of Income for fiscal 2019 was approximately $3.9 million. | [
{
"currency_/_unit": "USD",
"end_character": 277,
"end_date_for_period": "2019-12-28",
"label": "revenues",
"start_character": 274,
"start_date_for_period": "2019-10-09",
"value": 3900000
}
] |
10-K | 0001059556-20-000005 | 20200221184329 | 20191231 | MOODYS CORP /DE/ | On January 1, 2018, the Company adopted ASU No. 2014-09, “Revenue from Contracts with Customers (ASC Topic 606)” using the modified retrospective approach. Under the previous accounting guidance, the reduction to reported 2018 revenue, operating income and Net Income would have been a reduction of $13 million, $24 million and $19 million, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 302,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 300,
"start_date_for_period": "2018-01-01",
"value": 13000000
},
{
"currency_/_unit": "USD",
"end_character": 315,
"end_date_for_period": "2018-12-31",
"label": "ebit",
"start_character": 313,
"start_date_for_period": "2018-01-01",
"value": 24000000
},
{
"currency_/_unit": "USD",
"end_character": 331,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 329,
"start_date_for_period": "2018-01-01",
"value": 19000000
}
] |
10-K | 0001080657-20-000013 | 20200312173901 | 20191231 | Presidio Property Trust, Inc. | For the year ended December 31, 2019, the basic and diluted net loss per share are equivalent at $(0.03) per share because the Company had incurred a net loss causing any potentially dilutive securities to be anti-dilutive. For the year ended December 31, 2018, the basic and diluted net loss per share are equivalent at $0.19 because the Company had incurred a net loss causing any potentially dilutive securities to be anti-dilutive. Dilutive securities include non-vested restricted shares issued under the Company’s share-based incentive plan, shares issuable under certain of the Company’s partnership arrangements and shares issuable under stock purchase warrants. The calculation of net income (loss) per share includes dilutive shares totaling 746,517 shares for the year ended December 31, 2019 and excludes shares totaling 733,944 shares for the year ended December 31, 2018. | [
{
"currency_/_unit": null,
"end_character": 103,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 99,
"start_date_for_period": "2019-01-01",
"value": -0.03
},
{
"currency_/_unit": null,
"end_character": 326,
"end_date_for_period": "2018-12-31",
"label": "eps",
"start_character": 322,
"start_date_for_period": "2018-01-01",
"value": 0.19
},
{
"currency_/_unit": "shares",
"end_character": 759,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 752,
"start_date_for_period": "2019-01-01",
"value": 746517
},
{
"currency_/_unit": "shares",
"end_character": 840,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 833,
"start_date_for_period": "2018-01-01",
"value": 733944
}
] |
10-K | 0001084991-20-000011 | 20200331172130 | 20191231 | NATURAL GAS SERVICES GROUP INC | In January 2019, the Company reviewed the estimated useful lives of its rental equipment. This review indicated that the actual lives of its larger horsepower rental equipment were longer than the estimated useful lives used for depreciation purposes in the Company’s financial statements. These units incorporate newer technology and heavier, more robust castings and forging, which allows for complete overhauls at longer cycles when compared to its older, lower horsepower units. Accordingly, as of January 1, 2019, the Company changed its estimates of the useful lives of for these higher horsepower units from 15 years to 20 years (for its 400-600 horsepower units) or 25 years (for its 1,380 horsepower units). This analysis is consistent with our peers, which are depreciating their compressor units over 20 to 30 years. The effect of this change in estimate was to reduce 2019 depreciation expense by approximately $1.47 million, decrease 2019 net loss by $1.13 million, and decrease 2019 basic and diluted loss per share by $0.09. | [
{
"currency_/_unit": "USD",
"end_character": 930,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 926,
"start_date_for_period": "2019-01-01",
"value": 1470000
},
{
"currency_/_unit": "USD",
"end_character": 971,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 967,
"start_date_for_period": "2019-01-01",
"value": 1130000
},
{
"currency_/_unit": null,
"end_character": 1040,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 1036,
"start_date_for_period": "2019-01-01",
"value": 0.09
}
] |
10-K | 0001104506-20-000007 | 20200225073050 | 20191231 | INSMED Inc | The Company had $487.4 million in cash and cash equivalents as of December 31, 2019 and reported a net loss of $254.3 million for the year ended December 31, 2019. Historically, the Company has funded its operations primarily through public offerings of equity securities and debt financings. The Company commenced commercial shipments of ARIKAYCE in October 2018. The Company expects to continue to incur operating losses both at its US and certain international entities while funding research and development (R&D) activities for ARIKAYCE and its other pipeline programs, continuing commercialization activities for ARIKAYCE in the US, continuing to invest in pre-commercial and regulatory activities for ARIKAYCE in Europe and Japan, and funding other general and administrative activities. | [
{
"currency_/_unit": "USD",
"end_character": 22,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 17,
"start_date_for_period": "2019-12-31",
"value": 487400000
},
{
"currency_/_unit": "USD",
"end_character": 117,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 112,
"start_date_for_period": "2019-01-01",
"value": -254300000
}
] |
10-K | 0001104659-20-023889 | 20200221162631 | 20191231 | AMERICAN INTERNATIONAL GROUP INC | 98 million. The out of period adjustments are primarily related to decreases in deferred policy acquisition costs and increases in policyholder contract deposits. We determined that these adjustments were not material to the current year or to any previously reported annual financial statements. Had these adjustments been recorded in their appropriate periods, Net income attributable to AIG for the year ended December 31, 2017 would have increased by $ | [
{
"currency_/_unit": "USD",
"end_character": 2,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 0,
"start_date_for_period": "2018-01-01",
"value": -98000000
}
] |
10-K | 0001104659-20-023889 | 20200221162631 | 20191231 | AMERICAN INTERNATIONAL GROUP INC | 132 million. The out of period adjustments for the three-month period are primarily related to decreases in Premiums and decreases in Net realized capital gains and losses. We determined that these adjustments were not material to the current quarter or to any previously reported quarterly financial statements. Had these adjustments been recorded in their appropriate periods, Net income attributable to AIG common shareholders for the three-month period ended September 30, 2018 would have decreased by $ | [
{
"currency_/_unit": "USD",
"end_character": 3,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 0,
"start_date_for_period": "2018-10-01",
"value": -132000000
}
] |
10-K | 0001104659-20-027034 | 20200228151738 | 20191231 | MARINE PRODUCTS CORP | During the year ended December 31, 2019, the Company recorded rental income of $147 thousand that is classified as part of selling, general and administrative expenses in the consolidated statements of operations. | [
{
"currency_/_unit": "USD",
"end_character": 83,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 80,
"start_date_for_period": "2019-01-01",
"value": 147000
}
] |
10-K | 0001125345-20-000031 | 20200225160416 | 20191231 | MACROGENICS INC | Revenue associated with each performance obligation was recognized as the research and development services were provided using a cost-based input method according to research and development costs incurred to date compared to estimated total research and development costs. The transfer of control occurred over this time period and, in management’s judgment, was the best measure of progress towards satisfying the performance obligation. No revenue was recognized related to the MGD007 option during the year ended December 31, 2019. During the years ended December 31, 2018 and 2017, the Company recognized revenue of $1.9 million and $1.1 million, respectively, related to the MGD007 option. No revenue was deferred related to the MGD007 option at December 31, 2018. | [
{
"currency_/_unit": "USD",
"end_character": 443,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 441,
"start_date_for_period": "2019-01-01",
"value": 0
},
{
"currency_/_unit": "USD",
"end_character": 626,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 623,
"start_date_for_period": "2018-01-01",
"value": 1900000
},
{
"currency_/_unit": "USD",
"end_character": 643,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 640,
"start_date_for_period": "2017-01-01",
"value": 1100000
},
{
"currency_/_unit": "USD",
"end_character": 699,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 697,
"start_date_for_period": "2019-01-01",
"value": 0
}
] |
10-K | 0001125345-20-000031 | 20200225160416 | 20191231 | MACROGENICS INC | During the years ended December 31, 2019, 2018 and 2017 the Company recognized revenue of $11.6 million, $1.2 million, and $1.4 million, respectively, related to the flotetuzumab license grant fee. At December 31, 2019, $1.0 million of revenue related to the flotetuzumab license grant fee was deferred, all of which was current. | [
{
"currency_/_unit": "USD",
"end_character": 95,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 91,
"start_date_for_period": "2019-01-01",
"value": 11600000
},
{
"currency_/_unit": "USD",
"end_character": 109,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 106,
"start_date_for_period": "2018-01-01",
"value": 1200000
},
{
"currency_/_unit": "USD",
"end_character": 127,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 124,
"start_date_for_period": "2017-01-01",
"value": 1400000
},
{
"currency_/_unit": "USD",
"end_character": 224,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 221,
"start_date_for_period": "2019-12-31",
"value": 1000000
}
] |
10-K | 0001125345-20-000031 | 20200225160416 | 20191231 | MACROGENICS INC | Due to the relatively short-term nature of the recognition period, the revenue associated with the MGD013 performance obligation is being recognized on a straight-line basis as the Company performs research and development activities under the agreement. The fixed consideration related to the margetuximab performance obligation is also being recognized on a straight-line basis as the Company performs research and development activities under the agreement. Straight-line recognition is materially consistent with the pattern of performance of the research and development activities of each product candidate. The variable consideration related to the margetuximab performance obligation will be recognized upon certain regulatory achievements. During the years ended December 31, 2019 and 2018, the Company recognized revenue of $16.1 million and $1.3 million, respectively, related to the Zai Lab Agreement. At December 31, 2019, $5.0 million of revenue was deferred under this agreement, all of which was current. In February 2020, Zai Lab announced that the first patients were | [
{
"currency_/_unit": "USD",
"end_character": 839,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 835,
"start_date_for_period": "2019-01-01",
"value": 16100000.000000002
},
{
"currency_/_unit": "USD",
"end_character": 856,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 853,
"start_date_for_period": "2018-01-01",
"value": 1300000
},
{
"currency_/_unit": "USD",
"end_character": 940,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 937,
"start_date_for_period": "2019-12-31",
"value": 5000000
}
] |
10-K | 0001125345-20-000031 | 20200225160416 | 20191231 | MACROGENICS INC | During the year ended December 31, 2019, the Company entered into two agreements under which the Company is to perform manufacturing services for Zai Lab’s clinical needs of margetuximab and MGD013 (Zai Lab Clinical Supply Agreements). The Company evaluated the agreements under ASC 606 and determined that they should be accounted for as a single contract and identified two performance obligations within that contract: to perform services related to manufacturing the clinical supply of margetuximab and MGD013. The transaction price is based on the costs incurred to manufacture drug product and drug substance, and is recognized over time as the services are provided, as the performance by the Company does not create an asset with an alternative use and the Company has an enforceable right to payment for the performance completed to date. During the year ended December 31, 2019, the Company recognized revenue of $2.2 million related to the Zai Lab Clinical Supply Agreements. | [
{
"currency_/_unit": "USD",
"end_character": 927,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 924,
"start_date_for_period": "2019-01-01",
"value": 2200000
}
] |
10-K | 0001125345-20-000031 | 20200225160416 | 20191231 | MACROGENICS INC | The $10.0 million transaction price was being recognized over the expected research period, which was originally 30 months, using a cost-based input method to measure performance. Upon notice of Roche's intent to terminate the agreement in August 2019, the recognition period was adjusted to end in November 2019. The Company recognized revenue under this agreement of $6.0 million and $4.0 million, respectively, during the years ended December 31, 2019 and 2018. There was no revenue deferred under this agreement at December 31, 2019. At December 31, 2018, $6.0 million was deferred under this agreement, $4.0 million of which was current and $2.0 million of which was non-current. | [
{
"currency_/_unit": "USD",
"end_character": 9,
"end_date_for_period": "2017-12-31",
"label": "XBRL-OOS",
"start_character": 5,
"start_date_for_period": "2017-12-31",
"value": 10000000
},
{
"currency_/_unit": "USD",
"end_character": 373,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 370,
"start_date_for_period": "2019-01-01",
"value": 6000000
},
{
"currency_/_unit": "USD",
"end_character": 390,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 387,
"start_date_for_period": "2018-01-01",
"value": 4000000
},
{
"currency_/_unit": "USD",
"end_character": 477,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 475,
"start_date_for_period": "2019-12-31",
"value": 0
},
{
"currency_/_unit": "USD",
"end_character": 565,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 562,
"start_date_for_period": "2019-01-01",
"value": 6000000
},
{
"currency_/_unit": "USD",
"end_character": 613,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 610,
"start_date_for_period": "2018-01-01",
"value": 4000000
},
{
"currency_/_unit": "USD",
"end_character": 651,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 648,
"start_date_for_period": "2018-12-31",
"value": 2000000
}
] |
10-K | 0001171200-20-000103 | 20200228170241 | 20191231 | ROLLINS INC | Royalties
from Orkin franchises are accrued and recognized as revenues are earned on a monthly basis. Revenue from Orkin franchises was
$8.7 million for the year ended December 31, 2019 and $8.8 million and $5.4 million for the years ended December 31, 2018
and 2017, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 140,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 137,
"start_date_for_period": "2019-01-01",
"value": 8700000
},
{
"currency_/_unit": "USD",
"end_character": 194,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 191,
"start_date_for_period": "2018-01-01",
"value": 8800000
},
{
"currency_/_unit": "USD",
"end_character": 211,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 208,
"start_date_for_period": "2017-01-01",
"value": 5400000
}
] |
10-K | 0001171200-20-000103 | 20200228170241 | 20191231 | ROLLINS INC | Combined
domestic and international revenues from Orkin, Critter Control and Australia franchises were $17.1 million for the year ended
December 31, 2019 and $14.7 million and $9.7 million for the years ended December 31, 2018 and 2017, respectively. Total franchising
revenues were less than 1.0% of the Company’s annual revenues. | [
{
"currency_/_unit": "USD",
"end_character": 108,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 104,
"start_date_for_period": "2019-01-01",
"value": 17100000
},
{
"currency_/_unit": "USD",
"end_character": 163,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 159,
"start_date_for_period": "2018-01-01",
"value": 14700000
},
{
"currency_/_unit": "USD",
"end_character": 180,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 177,
"start_date_for_period": "2017-01-01",
"value": 9700000
}
] |
10-K | 0001258602-20-000019 | 20200227164107 | 20191231 | NELNET INC | Union Bank leases approximately 4,000 square feet in the Company's corporate headquarters building. Union Bank paid the Company approximately $79,000, $76,000, and $74,000 for commercial rent and storage income during 2019, 2018, and 2017, respectively. The lease agreement expires on June 30, 2023. | [
{
"currency_/_unit": "utr:sqft",
"end_character": 37,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 32,
"start_date_for_period": "2019-01-01",
"value": 4000
},
{
"currency_/_unit": "USD",
"end_character": 149,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 143,
"start_date_for_period": "2019-01-01",
"value": 79000
},
{
"currency_/_unit": "USD",
"end_character": 158,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 152,
"start_date_for_period": "2018-01-01",
"value": 76000
},
{
"currency_/_unit": "USD",
"end_character": 171,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 165,
"start_date_for_period": "2017-01-01",
"value": 74000
}
] |
10-K | 0001305323-20-000019 | 20200220163520 | 20191231 | Zovio Inc | The assets and liabilities of Fullstack were recorded on the Company’s consolidated balance sheets at their estimated fair values as of April 1, 2019, the acquisition date. Fullstack’s results of operations are included in the Company’s consolidated statements of income (loss) from that date. Fullstack recognized revenue of $9.2 million, had an operating loss of $10.6 million, | [
{
"currency_/_unit": "USD",
"end_character": 330,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 327,
"start_date_for_period": "2019-10-01",
"value": 9200000
},
{
"currency_/_unit": "USD",
"end_character": 370,
"end_date_for_period": "2019-12-31",
"label": "ebit",
"start_character": 366,
"start_date_for_period": "2019-10-01",
"value": 10600000
}
] |
10-K | 0001305323-20-000019 | 20200220163520 | 20191231 | Zovio Inc | The Fullstack Contingent Consideration will become issuable, subject to the terms and conditions of the Fullstack Merger Agreement. Of the total contingent 2,250,000 shares, (i) 1,250,000 are based upon final determination of the achievement of certain employee retention requirements and is being expensed over the retention period, (ii) 500,000 shares are based upon revenue performance in 2019 and 2020, earned on a sliding scale, in the event that the revenues for Fullstack are between $25.0 million and $35.0 million, and (iii) 500,000 shares are based upon contract performance milestones in 2019 and 2020, earned on a sliding scale, in the event that Fullstack obtains between four and eight new university contracts. The fair value of the performance based Fullstack Contingent Consideration arrangements was estimated by applying a Monte Carlo simulation, based upon the result of forecast information. These measures are based upon significant inputs that are not observable by the market, and are therefore deemed to be Level 3 inputs. At each subsequent reporting date, the Company will remeasure the | [
{
"currency_/_unit": "shares",
"end_character": 165,
"end_date_for_period": "2019-04-01",
"label": "eps",
"start_character": 156,
"start_date_for_period": "2019-04-01",
"value": 2250000
},
{
"currency_/_unit": "shares",
"end_character": 187,
"end_date_for_period": "2019-04-01",
"label": "eps",
"start_character": 178,
"start_date_for_period": "2019-04-01",
"value": 1250000
},
{
"currency_/_unit": "shares",
"end_character": 346,
"end_date_for_period": "2019-04-01",
"label": "eps",
"start_character": 339,
"start_date_for_period": "2019-04-01",
"value": 500000
},
{
"currency_/_unit": "USD",
"end_character": 496,
"end_date_for_period": "2019-04-01",
"label": "XBRL-OOS",
"start_character": 492,
"start_date_for_period": "2019-04-01",
"value": 25000000
},
{
"currency_/_unit": "USD",
"end_character": 514,
"end_date_for_period": "2019-04-01",
"label": "XBRL-OOS",
"start_character": 510,
"start_date_for_period": "2019-04-01",
"value": 35000000
},
{
"currency_/_unit": "shares",
"end_character": 541,
"end_date_for_period": "2019-04-01",
"label": "eps",
"start_character": 534,
"start_date_for_period": "2019-04-01",
"value": 500000
}
] |
10-K | 0001305323-20-000019 | 20200220163520 | 20191231 | Zovio Inc | The assets and liabilities of TutorMe were recorded on the Company’s consolidated balance sheets at their estimated fair values as of April 3, 2019, the acquisition date. TutorMe’s results of operations are included in the Company’s consolidated statements of income (loss) from that date. TutorMe recognized revenue of $0.9 million, had an operating loss of $3.2 million, and net loss of $3.2 million for the period from acquisition through December 31, 2019. See additional supplemental pro forma financial information below. For the twelve months ended December 31, 2019, the Company recorded acquisition-related expenses of $1.9 million, in general and administrative on the consolidated statements of income (loss), associated with the TutorMe acquisition. The Company accounts for business combinations using the acquisition method of accounting. | [
{
"currency_/_unit": "USD",
"end_character": 324,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 321,
"start_date_for_period": "2019-10-01",
"value": 900000
},
{
"currency_/_unit": "USD",
"end_character": 363,
"end_date_for_period": "2019-12-31",
"label": "ebit",
"start_character": 360,
"start_date_for_period": "2019-10-01",
"value": 3200000
},
{
"currency_/_unit": "USD",
"end_character": 393,
"end_date_for_period": "2019-12-31",
"label": "ebit",
"start_character": 390,
"start_date_for_period": "2019-10-01",
"value": 3200000
},
{
"currency_/_unit": "USD",
"end_character": 632,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 629,
"start_date_for_period": "2019-01-01",
"value": 1900000
}
] |
10-K | 0001318568-20-000017 | 20200302161702 | 20191231 | Everi Holdings Inc. | Equipment revenues are derived from the sale of our cash access and loyalty kiosks and related equipment and are accounted for under ASC 606, unless such transactions meet definition of a sales type or direct financing lease which are accounted for under ASC 842. Revenues are recognized at a point in time when control of the promised goods and services transfers to the customer generally upon shipment or delivery pursuant to the terms of the contract. The sales contracts are generally short-term in nature with payment terms ranging from 30 to 90 days, while certain agreements provide for extended payment terms of up to 60 months. Each contract containing extended payment terms over a period of 12 months is evaluated for the presence of a financing component; however, our contracts generally do not contain a financing component that has been determined to be significant to the contract. The cash access kiosk and related equipment sales contracts accounted for under ASC 842 were approximately $2.6 million in aggregate revenue for the year ended December 31, 2019. We did not have any cash access kiosk and related equipment sales transactions that qualified for sales type lease accounting treatment in 2018 or 2017. | [
{
"currency_/_unit": "USD",
"end_character": 1010,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 1007,
"start_date_for_period": "2019-01-01",
"value": 2600000
}
] |
10-K | 0001336917-20-000010 | 20200226160339 | 20191231 | Under Armour, Inc. | In addition to the investment in Dome, the Company has a license agreement with Dome. The Company recorded license revenues from Dome of $37.8 million and $35.6 million for the years ended December 31, 2019 and 2018, respectively. As of December 31, 2019 and 2018, respectively, the Company had $15.6 million and $13.1 million in licensing receivables outstanding, recorded in the prepaid expenses and other current assets line item within the Company's consolidated balance sheet. | [
{
"currency_/_unit": "USD",
"end_character": 142,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 138,
"start_date_for_period": "2019-01-01",
"value": 37800000
},
{
"currency_/_unit": "USD",
"end_character": 160,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 156,
"start_date_for_period": "2018-01-01",
"value": 35600000
},
{
"currency_/_unit": "USD",
"end_character": 300,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 296,
"start_date_for_period": "2019-12-31",
"value": 15600000
},
{
"currency_/_unit": "USD",
"end_character": 318,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 314,
"start_date_for_period": "2018-12-31",
"value": 13100000
}
] |
10-K | 0001336917-20-000010 | 20200226160339 | 20191231 | Under Armour, Inc. | As of December 31, 2019, approximately $165.4 million of cash and cash equivalents was held by the Company's non-U.S. subsidiaries whose cumulative undistributed earnings total $765.5 million. The Tax Act imposed U.S. federal tax on all post-1986 foreign unrepatriated earnings accumulated through December 31, 2017. The portion of these earnings not subject to U.S. federal income tax as part of the one-time transition tax should, in general, not be subject to U.S. federal income tax. The Company will continue to permanently reinvest these earnings, as well as future earnings from our foreign subsidiaries, to fund international growth and operations. If the Company were to repatriate indefinitely reinvested foreign funds, the Company would still be required to accrue and pay certain taxes upon repatriation, including foreign withholding taxes and certain U.S. state taxes and record foreign exchange rate impacts. Determination of the unrecorded deferred tax liability that would be incurred if such amounts were repatriated is not practicable. | [
{
"currency_/_unit": "USD",
"end_character": 45,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 40,
"start_date_for_period": "2019-12-31",
"value": 165400000
},
{
"currency_/_unit": "USD",
"end_character": 183,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 178,
"start_date_for_period": "2019-01-01",
"value": 765500000
}
] |
10-K | 0001336917-20-000010 | 20200226160339 | 20191231 | Under Armour, Inc. | Net revenues in the United States were $3,394.0 million, $3,464.0 million, and $3,626.6 million for the years ended December 31, 2019, 2018 and 2017, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 47,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 40,
"start_date_for_period": "2019-01-01",
"value": 3394000000
},
{
"currency_/_unit": "USD",
"end_character": 65,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 58,
"start_date_for_period": "2018-01-01",
"value": 3464000000
},
{
"currency_/_unit": "USD",
"end_character": 87,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 80,
"start_date_for_period": "2017-01-01",
"value": 3626600000
}
] |
10-K | 0001345016-20-000009 | 20200228171758 | 20191231 | YELP INC | The Company completed the integration of Turnstyle's operations into those of the Company during the three months ended December 31, 2017 and, as such, determining Turnstyle's contribution to the net income of the Company for the years ended December 31, 2019 and 2018 is impracticable. The consolidated statement of operations for the year ended December 31, 2017 includes $8.8 million of net loss attributable to Turnstyle. | [
{
"currency_/_unit": "USD",
"end_character": 378,
"end_date_for_period": "2017-12-31",
"label": "earnings",
"start_character": 375,
"start_date_for_period": "2017-01-01",
"value": -8800000
}
] |
10-K | 0001378453-20-000009 | 20200225111156 | 20191231 | TravelCenters of America Inc. /MD/ | Reflects the retrospective adjustment related to the reverse stock split completed on August 1, 2019, and excludes unvested shares of common stock awarded under our Share Award Plans, which shares of common stock are considered participating securities because they participate equally in earnings and losses with all of our other shares of common stock. The weighted average number of unvested shares of common stock outstanding was 316 and 341 for the years ended December 31, 2019 and 2018, respectively. | [
{
"currency_/_unit": "shares",
"end_character": 437,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 434,
"start_date_for_period": "2019-01-01",
"value": 316000
},
{
"currency_/_unit": "shares",
"end_character": 445,
"end_date_for_period": "2018-12-31",
"label": "eps",
"start_character": 442,
"start_date_for_period": "2018-01-01",
"value": 341000
}
] |
10-K | 0001403256-20-000066 | 20200224165630 | 20191231 | Sculptor Capital Management, Inc. | For the years ended December 31, 2019, 2018 and 2017, the Company included 180,444, 142,512 and 110,373 RSUs respectively, that have vested but have not been settled in Class A Shares in the weighted-average Class A Shares outstanding used to calculate basic and diluted earnings (loss) per Class A Share. | [
{
"currency_/_unit": "shares",
"end_character": 82,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 75,
"start_date_for_period": "2019-01-01",
"value": 180444
},
{
"currency_/_unit": "shares",
"end_character": 91,
"end_date_for_period": "2018-12-31",
"label": "eps",
"start_character": 84,
"start_date_for_period": "2018-01-01",
"value": 142512
},
{
"currency_/_unit": "shares",
"end_character": 103,
"end_date_for_period": "2017-12-31",
"label": "eps",
"start_character": 96,
"start_date_for_period": "2017-01-01",
"value": 110373
}
] |
10-K | 0001418091-20-000037 | 20200218175351 | 20191231 | TWITTER, INC. | Since the Company expects to settle the principal amount of the outstanding Convertible Notes in cash, the Company uses the treasury stock method for calculating any potential dilutive effect of the conversion spread on diluted net income per share, if applicable. For the 2021 Notes, the conversion spread of 12.3 million shares will have a dilutive impact on diluted net income per share of common stock when the average market price of the Company’s common stock for a given period exceeds the conversion price of $77.64 per share. For the 2024 Notes, the conversion spread of 20.1 million shares will have a dilutive impact on diluted net income per share of common stock when the average market price of the Company’s common stock for a given period exceeds the conversion price of $57.14 per share. | [
{
"currency_/_unit": "shares",
"end_character": 314,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 310,
"start_date_for_period": "2019-01-01",
"value": 12300000
},
{
"currency_/_unit": null,
"end_character": 523,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 518,
"start_date_for_period": "2019-12-31",
"value": 77.64
},
{
"currency_/_unit": "shares",
"end_character": 584,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 580,
"start_date_for_period": "2019-01-01",
"value": 20100000
},
{
"currency_/_unit": null,
"end_character": 793,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 788,
"start_date_for_period": "2019-12-31",
"value": 57.14
}
] |
10-K | 0001433714-20-000016 | 20200228162908 | 20191231 | CASTLIGHT HEALTH, INC. | Loss before income tax benefit was $40.0 million, $39.7 million and $57.1 million for years ended December 31, 2019, 2018 and 2017, respectively, all from domestic operations. | [
{
"currency_/_unit": "USD",
"end_character": 40,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 36,
"start_date_for_period": "2019-01-01",
"value": -40000000
},
{
"currency_/_unit": "USD",
"end_character": 55,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 51,
"start_date_for_period": "2018-01-01",
"value": -39700000
},
{
"currency_/_unit": "USD",
"end_character": 73,
"end_date_for_period": "2017-12-31",
"label": "earnings",
"start_character": 69,
"start_date_for_period": "2017-01-01",
"value": -57100000
}
] |
10-K | 0001436126-20-000018 | 20200327172033 | 20191231 | Mistras Group, Inc. | Net income (loss) of foreign subsidiaries was $2.5 million, $2.0 million, and $4.1 million for the years ended December 31, 2019, 2018 and 2017, respectively. Generally, it has been the Company's practice and intention to reinvest the earnings of its non-U.S. subsidiaries in those operations. As previously noted, the Tax Act made significant changes to the taxation of undistributed earnings, requiring that all previously untaxed earnings and profits of the Company's controlled foreign operations be subjected to the transition tax. Since these earnings have now been subjected to U.S. federal tax they would only be potentially subject to limited other taxes, including foreign withholding and certain state taxes. As of December 31, 2019, the Company has not recognized a deferred tax liability for foreign withholdings and state taxes on its undistributed international earnings or losses of its foreign subsidiaries since it intends to indefinitely reinvest the earnings outside the United States. The Company has estimated that the amount of the unrecorded deferred tax liability related to undistributed international earnings is approximately $1.1 million. | [
{
"currency_/_unit": "USD",
"end_character": 50,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 47,
"start_date_for_period": "2019-01-01",
"value": 2500000
},
{
"currency_/_unit": "USD",
"end_character": 64,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 61,
"start_date_for_period": "2018-01-01",
"value": 2000000
},
{
"currency_/_unit": "USD",
"end_character": 82,
"end_date_for_period": "2016-12-31",
"label": "earnings",
"start_character": 79,
"start_date_for_period": "2016-06-01",
"value": 4099999.9999999995
},
{
"currency_/_unit": "USD",
"end_character": 254,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 252,
"start_date_for_period": "2019-12-31",
"value": 0
},
{
"currency_/_unit": "USD",
"end_character": 1162,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 1159,
"start_date_for_period": "2019-12-31",
"value": 1100000
}
] |
10-K | 0001466538-20-000026 | 20200304082716 | 20191231 | COWEN INC. | Included in the accompanying consolidated statements of operations for the year ended December 31, 2019 is revenue of $34.8 million and net income of $5.7 million related to the results of operations of Quarton. | [
{
"currency_/_unit": "USD",
"end_character": 123,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 119,
"start_date_for_period": "2019-01-01",
"value": 34800000
},
{
"currency_/_unit": "USD",
"end_character": 154,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 151,
"start_date_for_period": "2019-01-01",
"value": 5700000
}
] |
10-K | 0001476150-20-000003 | 20200206160428 | 20191231 | Terreno Realty Corp | The Company recorded revenues and net income for the year ended December 31, 2019 of approximately $7.6 million and $3.0 million, respectively, related to the 2019 acquisitions. | [
{
"currency_/_unit": "USD",
"end_character": 103,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 100,
"start_date_for_period": "2019-01-01",
"value": 7600000
},
{
"currency_/_unit": "USD",
"end_character": 120,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 117,
"start_date_for_period": "2019-01-01",
"value": 3000000
}
] |
10-K | 0001476150-20-000003 | 20200206160428 | 20191231 | Terreno Realty Corp | The Company recorded revenues and net income for the year ended December 31, 2018 of approximately $4.8 million and $1.7 million, respectively, related to the 2018 acquisitions. | [
{
"currency_/_unit": "USD",
"end_character": 103,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 100,
"start_date_for_period": "2018-01-01",
"value": 4800000
},
{
"currency_/_unit": "USD",
"end_character": 120,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 117,
"start_date_for_period": "2018-01-01",
"value": 1700000
}
] |
10-K | 0001476150-20-000003 | 20200206160428 | 20191231 | Terreno Realty Corp | In accordance with the Company’s policies of determining whether instruments granted in share-based payment transactions are participating securities and accounting for earnings per share, the net income (loss) per common share is adjusted for earnings distributed through declared dividends (if any) and allocated to all participating securities (weighted average common shares outstanding and unvested restricted shares outstanding) under the two-class method. Under this method, allocations were made to 402,380, 368,912 and 375,924 of weighted average unvested restricted shares outstanding for the years ended December 31, 2019, 2018 and 2017, respectively. | [
{
"currency_/_unit": "shares",
"end_character": 514,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 507,
"start_date_for_period": "2019-01-01",
"value": 402380
},
{
"currency_/_unit": "shares",
"end_character": 523,
"end_date_for_period": "2018-12-31",
"label": "eps",
"start_character": 516,
"start_date_for_period": "2018-01-01",
"value": 368912
},
{
"currency_/_unit": "shares",
"end_character": 535,
"end_date_for_period": "2017-12-31",
"label": "eps",
"start_character": 528,
"start_date_for_period": "2017-01-01",
"value": 375924
}
] |
10-K | 0001564590-20-007421 | 20200227164041 | 20191231 | Live Oak Bancshares, Inc. | Lease income of $9.4 million, $8.0 million and $1.9 million was recognized in the twelve months ended December 31, 2019, 2018 and 2017, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 20,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 17,
"start_date_for_period": "2019-01-01",
"value": 9400000
},
{
"currency_/_unit": "USD",
"end_character": 34,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 31,
"start_date_for_period": "2018-01-01",
"value": 8000000
},
{
"currency_/_unit": "USD",
"end_character": 51,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 48,
"start_date_for_period": "2017-01-01",
"value": 1900000
}
] |
10-K | 0001564590-20-008129 | 20200302155215 | 20191231 | NEXSTAR MEDIA GROUP, INC. | The station’s net revenue of $7.6 million and operating income of $4.6 million in 2018 have been included in the accompanying Consolidated Statements of Operations | [
{
"currency_/_unit": "USD",
"end_character": 33,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 30,
"start_date_for_period": "2018-01-01",
"value": 7600000
},
{
"currency_/_unit": "USD",
"end_character": 70,
"end_date_for_period": "2018-12-31",
"label": "ebit",
"start_character": 67,
"start_date_for_period": "2018-01-01",
"value": 4600000
}
] |
10-K | 0001564590-20-008211 | 20200302173321 | 20191231 | Tilray, Inc. | For the fiscal year ended December 31, 2019 the Company reported a consolidated net loss of $321,169 and a net loss of $67,723 and $7,809 for the year ending December 31, 2018 and December 31, 2017, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 100,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 93,
"start_date_for_period": "2019-01-01",
"value": -321169000
},
{
"currency_/_unit": "USD",
"end_character": 126,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 120,
"start_date_for_period": "2018-01-01",
"value": -67723000
},
{
"currency_/_unit": "USD",
"end_character": 137,
"end_date_for_period": "2017-12-31",
"label": "earnings",
"start_character": 132,
"start_date_for_period": "2017-01-01",
"value": -7809000
}
] |
10-K | 0001599947-20-000012 | 20200317165736 | 20191231 | TerraForm Power, Inc. | The Company earned $338.7 million and $186.7 million from the Spanish Electricity System for the years ended December 31, 2019, and 2018, respectively, of which $240.7 million and $127.9 million were through collections from the Comisión Nacional de los Mercados y la Competencia (“CNMC”). These operating revenues were earned within the Regulated Solar and Wind segment and represented 25.6% and 16.7% of the Company’s net consolidated operating revenues for these years, respectively. The CNMC is the state-owned regulator of the Spanish Electricity System who collects the funds payable, mainly from the tariffs to end user customers, and is responsible for the calculation and the settlement of regulated payments. | [
{
"currency_/_unit": "USD",
"end_character": 25,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 20,
"start_date_for_period": "2019-01-01",
"value": 338700000
},
{
"currency_/_unit": "USD",
"end_character": 44,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 39,
"start_date_for_period": "2018-01-01",
"value": 186700000
},
{
"currency_/_unit": "USD",
"end_character": 167,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 162,
"start_date_for_period": "2019-01-01",
"value": 240700000
},
{
"currency_/_unit": "USD",
"end_character": 186,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 181,
"start_date_for_period": "2018-01-01",
"value": 127900000
},
{
"currency_/_unit": "pure",
"end_character": 391,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 387,
"start_date_for_period": "2019-01-01",
"value": 0.256
},
{
"currency_/_unit": "pure",
"end_character": 401,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 397,
"start_date_for_period": "2018-01-01",
"value": 0.167
}
] |
10-K | 0001599947-20-000012 | 20200317165736 | 20191231 | TerraForm Power, Inc. | The Company earned $93.9 million and $90.3 million operating revenues from the Tennessee Valley Authority (“TVA”) for the years ended December 31, 2019, and 2018, respectively. These operating revenues were earned within the Regulated Solar and Wind segment and represented 10.0% and 11.8% of the Company’s net consolidated operating revenues for these years, respectively. The TVA is a corporation wholly-owned by the U.S. government that sells power mainly to wholesale customers in several states in the Southern part on the U.S. | [
{
"currency_/_unit": "USD",
"end_character": 24,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 20,
"start_date_for_period": "2019-01-01",
"value": 93900000
},
{
"currency_/_unit": "USD",
"end_character": 42,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 38,
"start_date_for_period": "2018-01-01",
"value": 90300000
},
{
"currency_/_unit": "pure",
"end_character": 278,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 274,
"start_date_for_period": "2019-01-01",
"value": 0.1
},
{
"currency_/_unit": "pure",
"end_character": 288,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 284,
"start_date_for_period": "2018-01-01",
"value": 0.11800000000000001
}
] |
10-K | 0001628280-20-002244 | 20200226073958 | 20191231 | MGP INGREDIENTS INC | - Operating income for 2019 decreased to $47,242 from $50,148 for 2018, due to gross profit declines in both our Distillery Products and Ingredient Solutions segments. These decreases were partially offset by a decrease in SG&A expenses. | [
{
"currency_/_unit": "USD",
"end_character": 61,
"end_date_for_period": "2018-12-31",
"label": "ebit",
"start_character": 55,
"start_date_for_period": "2018-01-01",
"value": 50148000
}
] |
10-K | 0001628280-20-002244 | 20200226073958 | 20191231 | MGP INGREDIENTS INC | - Operating income for 2018 increased to $50,148 from $42,909 for 2017, due to gross profit growth in both our Distillery Products and Ingredient Solutions segments, partially offset by an increase in SG&A expenses. | [
{
"currency_/_unit": "USD",
"end_character": 48,
"end_date_for_period": "2018-12-31",
"label": "ebit",
"start_character": 42,
"start_date_for_period": "2018-01-01",
"value": 50148000
},
{
"currency_/_unit": "USD",
"end_character": 61,
"end_date_for_period": "2017-12-31",
"label": "ebit",
"start_character": 55,
"start_date_for_period": "2017-01-01",
"value": 42909000
}
] |
10-K | 0001628280-20-002244 | 20200226073958 | 20191231 | MGP INGREDIENTS INC | The cash provided by operating activities during 2018 resulted primarily from net income of $37,284, adjustments for non-cash or non-operating charges of $16,126 including depreciation and amortization, share-based compensation and deferred income taxes, partially offset by uses of cash due to change in operating assets and liabilities of $19,929. The primary drivers of the changes in operating assets and liabilities were $15,620 use of cash related to an increase in inventories driven primarily by barreled distillate and $4,450 use of cash related to an increase in receivables, net. The change in receivables, net is primarily related to the timing of sales and cash collections. | [
{
"currency_/_unit": "USD",
"end_character": 99,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 93,
"start_date_for_period": "2018-01-01",
"value": 37284000
}
] |
10-K | 0001628280-20-002244 | 20200226073958 | 20191231 | MGP INGREDIENTS INC | Participating securities included RSUs of 111,365, 326,375, and 368,492 for the years ended December 31, 2019, 2018, and 2017, respectively. | [
{
"currency_/_unit": "shares",
"end_character": 49,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 42,
"start_date_for_period": "2019-01-01",
"value": 111365
},
{
"currency_/_unit": "shares",
"end_character": 58,
"end_date_for_period": "2018-12-31",
"label": "eps",
"start_character": 51,
"start_date_for_period": "2018-01-01",
"value": 326375
},
{
"currency_/_unit": "shares",
"end_character": 71,
"end_date_for_period": "2017-12-31",
"label": "eps",
"start_character": 64,
"start_date_for_period": "2017-01-01",
"value": 368492
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $78 million decrease to net income was driven by the items described above in the consolidated statement of income for the year ended December 31, 2018 section. | [
{
"currency_/_unit": "USD",
"end_character": 7,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2018-01-01",
"value": -78000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $115 million decrease to net income was driven by the items described above in the consolidated statement of income for the year ended December 31, 2017 section. | [
{
"currency_/_unit": "USD",
"end_character": 8,
"end_date_for_period": "2017-12-31",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2017-01-01",
"value": -115000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $78 million decrease to net income was driven by the items described above in the consolidated statement of income for the year ended December 31, 2018 section. | [
{
"currency_/_unit": "USD",
"end_character": 7,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2018-01-01",
"value": -78000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $115 million decrease to net income was driven by the items described above in the consolidated statement of income for the year ended December 31, 2017 section. | [
{
"currency_/_unit": "USD",
"end_character": 8,
"end_date_for_period": "2017-12-31",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2017-01-01",
"value": -115000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $30 million decrease to net income was driven by the items described above in the consolidated statement of income for the three months ended June 30, 2019 section. | [
{
"currency_/_unit": "USD",
"end_character": 7,
"end_date_for_period": "2019-06-30",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2019-04-01",
"value": -30000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $35 million decrease to net income was driven by the items described above in the consolidated statement of income for the six months ended June 30, 2019 section. | [
{
"currency_/_unit": "USD",
"end_character": 7,
"end_date_for_period": "2019-06-30",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2019-01-01",
"value": -35000000
}
] |
Subsets and Splits